Identification of Basic Residues in the Heparin-binding Exosite of Factor Xa Critical for Heparin and Factor Va Binding*
暂无分享,去创建一个
[1] S. Bajaj,et al. Protease and EGF1 Domains of Factor IXa Play Distinct Roles in Binding to Factor VIIIa , 1999, The Journal of Biological Chemistry.
[2] K. R. Dharmawardana,et al. Demonstration of exosite I-dependent interactions of thrombin with human factor V and factor Va involving the factor Va heavy chain: analysis by affinity chromatography employing a novel method for active-site-selective immobilization of serine proteinases. , 1998, Biochemistry.
[3] A. Rezaie. Calcium Enhances Heparin Catalysis of the Antithrombin-Factor Xa Reaction by a Template Mechanism , 1998, The Journal of Biological Chemistry.
[4] A. Betz,et al. Regions Remote from the Site of Cleavage Determine Macromolecular Substrate Recognition by the Prothrombinase Complex* , 1998, The Journal of Biological Chemistry.
[5] A. Betz,et al. Exosites determine macromolecular substrate recognition by prothrombinase. , 1997, Biochemistry.
[6] C. Esmon,et al. Influence of Arginines 93, 97, and 101 of thrombin to its functional specificity. , 1997, Biochemistry.
[7] A. Rezaie. Role of Residue 99 at the S2 Subsite of Factor Xa and Activated Protein C in Enzyme Specificity* , 1996, The Journal of Biological Chemistry.
[8] C. Esmon,et al. Involvement of Thrombin Anion-binding Exosites 1 and 2 in the Activation of Factor V and Factor VIII* , 1996, The Journal of Biological Chemistry.
[9] A. Rezaie. Tryptophan 60-D in the B-insertion loop of thrombin modulates the thrombin-antithrombin reaction. , 1996, Biochemistry.
[10] C. Esmon,et al. Contribution of Residue 192 in Factor Xa to Enzyme Specificity and Function (*) , 1995, The Journal of Biological Chemistry.
[11] S. Olson,et al. Mechanism of Acceleration of Antithrombin-Proteinase Reactions by Low Affinity Heparin , 1995, The Journal of Biological Chemistry.
[12] C. Esmon,et al. Asp-70-->Lys mutant of factor X lacks high affinity Ca2+ binding site yet retains function. , 1994, Journal of Biological Chemistry.
[13] C. Esmon,et al. Glycosaminoglycan contributions to both protein C activation and thrombin inhibition involve a common arginine-rich site in thrombin that includes residues arginine 93, 97, and 101. , 1994, The Journal of biological chemistry.
[14] J. Sheehan,et al. Molecular mapping of the heparin-binding exosite of thrombin. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[15] Y. Li,et al. Identification of basic amino acid residues in thrombin essential for heparin-catalyzed inactivation by antithrombin III. , 1994, The Journal of biological chemistry.
[16] R. Huber,et al. Structure of human des(1-45) factor Xa at 2.2 A resolution. , 1993, Journal of molecular biology.
[17] C. Esmon,et al. Analysis of the functions of the first epidermal growth factor-like domain of factor X. , 1993, The Journal of biological chemistry.
[18] C. Esmon,et al. The function of calcium in protein C activation by thrombin and the thrombin-thrombomodulin complex can be distinguished by mutational analysis of protein C derivatives. , 1992, The Journal of biological chemistry.
[19] R. Carrell,et al. Heparin binding site, conformational change, and activation of antithrombin. , 1992, Biochemistry.
[20] S. Olson,et al. Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement. , 1992, The Journal of biological chemistry.
[21] H. James,et al. Molecular recognition sites on factor Xa which participate in the prothrombinase complex. , 1992, The Journal of biological chemistry.
[22] S. Thein,et al. Antithrombin and its deficiency states. , 1992, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[23] H. Halvorson,et al. Quantitative characterization of the thrombin-heparin interaction. Discrimination between specific and nonspecific binding models. , 1991, The Journal of biological chemistry.
[24] J. Stenflo,et al. The gamma-carboxyglutamic acid and epidermal growth factor-like domains of factor X. Effect of isolated domains on prothrombin activation and endothelial cell binding of factor X. , 1991, Journal of Biological Chemistry.
[25] B. Owen,et al. Interaction of factor Xa with heparin does not contribute to the inhibition of factor Xa by antithrombin III-heparin. , 1990, Biochemistry.
[26] Kenneth G. Mann,et al. Surface-dependent reactions of the vitamin K-dependent enzyme complexes , 1990 .
[27] A. Giles,et al. Studies of the role of factor Va in the factor Xa-catalyzed activation of prothrombin, fragment 1.2-prethrombin-2, and dansyl-L-glutamyl-glycyl-L-arginine-meizothrombin in the absence of phospholipid. , 1990, The Journal of biological chemistry.
[28] R. Huber,et al. The refined 1.9 A crystal structure of human alpha‐thrombin: interaction with D‐Phe‐Pro‐Arg chloromethylketone and significance of the Tyr‐Pro‐Pro‐Trp insertion segment. , 1989, The EMBO journal.
[29] H. Hemker,et al. Antithrombin III-dependent anti-prothrombinase activity of heparin and heparin fragments. , 1989, The Journal of biological chemistry.
[30] S. Olson,et al. Transient kinetics of heparin-catalyzed protease inactivation by antithrombin III. Characterization of assembly, product formation, and heparin dissociation steps in the factor Xa reaction. , 1989, The Journal of biological chemistry.
[31] C. Esmon,et al. The active site of blood coagulation factor Xa. Its distance from the phospholipid surface and its conformational sensitivity to components of the prothrombinase complex. , 1987, The Journal of biological chemistry.
[32] Å. Danielsson,et al. Role of ternary complexes, in which heparin binds both antithrombin and proteinase, in the acceleration of the reactions between antithrombin and thrombin or factor Xa. , 1986, The Journal of biological chemistry.
[33] K. Kurachi,et al. Gene for human factor X: a blood coagulation factor whose gene organization is essentially identical with that of factor IX and protein C. , 1986, Biochemistry.
[34] M. Scully,et al. The relative molecular mass dependence of the anti-factor Xa properties of heparin. , 1986, The Biochemical journal.
[35] C. Esmon,et al. Comparison of coagulation factor Xa and des-(1-44)factor Xa in the assembly of prothrombinase. , 1984, The Journal of biological chemistry.
[36] M. Griffith. Measurement of the heparin enhanced-antithrombin III/thrombin reaction rate in the presence of synthetic substrate. , 1982, Thrombosis research.
[37] G M Oosta,et al. The kinetics of hemostatic enzyme-antithrombin interactions in the presence of low molecular weight heparin. , 1980, The Journal of biological chemistry.
[38] F. Sanger,et al. DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[39] R. Rosenberg,et al. Anticoagulant Action of Heparin , 1973, Nature.
[40] S. Olson,et al. Regulation of Thrombin by Antithrombin and Heparin Cofactor II , 1992 .
[41] K. Mann,et al. Cofactor proteins in the assembly and expression of blood clotting enzyme complexes. , 1988, Annual review of biochemistry.
[42] M. Scully,et al. The acceleration of the inhibition of platelet prothrombinase complex by heparin. , 1986, The Biochemical journal.